TRHC - Tabula Rasa HealthCare preliminary Q2 results boost shares 55% but still down 74% YTD
- Tabula Rasa Healthcare ( TRHC ) is up 55% on Thursday after releasing preliminary Q2 2022 results after the closing bell Wednesday.
- Preliminary quarterly revenue is expected to be $72M–$73M, up for previous guidance of $66M–$69M.
- Tabula Rasa is expected to release Q2 earnings on Aug. 4.
- On Wednesday, Indaba Capital Management, the company's largest shareholder, called for management changes and board changes .
- Among seven Wall Street firms covering Tabula Rasa ( TRHC ), four rate the company a hold, two a strong buy, and one a hold.
- "While the revenue beat significantly de-risks guidance — the midpoint implies 4% 2H growth vs. 13% growth YTD — it did not include any color on profitability/cash flow, which has been a key watch item for TRHC," SVB Securities' Stephanie David wrote.
- Despite today's run-up, Tabula Rasa is still down 74% year to date.
For further details see:
Tabula Rasa HealthCare preliminary Q2 results boost shares 55%, but still down 74% YTD